Drug development and acute gastrointestinal infections

References

• Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014;59:132–152.
   PubMed Web of Science ®Google Scholar
• Parashar UD, Johnson H, Steele AD, et al. Health impact of rotavirus vaccination in developing countries: progress and way forward. Clin Infect Dis. 2016;62(Suppl 2):S91–S95.
   PubMedGoogle Scholar
• Alam NH, Ashraf H, Kamruzzaman M, et al. Efficacy of partially hydrolyzed guar gum (PHGG) supplemented modified oral rehydration solution in the treatment of severely malnourished children with watery diarrhoea: a randomised double-blind controlled trial. J Health Popul Nutr. 2015;34:3.
   PubMed Web of Science ®Google Scholar
• Thiagarajah JR, Ko EA, Tradtrantip L, et al. Discovery and development of antisecretory drugs for treating diarrheal diseases. Clin Gastroenterol Hepatol. 2014;12:204–209.
   PubMed Web of Science ®Google Scholar
• Thiagarajah JR, Donowitz M, Verkman AS. Secretory diarrhoea: mechanisms and emerging therapies. Nat Rev Gastroenterol Hepatol. 2015;12:446–457.
   PubMed Web of Science ®Google Scholar
• Donowitz M, Alpers DH, Binder HJ, et al. Translational approaches for pharmacotherapy development for acute diarrhea. Gastroenterology. 2012;142:e1–e9.
   PubMedGoogle Scholar
• Zaman S, Aamir K, Lange S, et al. Antisecretory factor effectively and safely stops childhood diarrhoea: a placebo-controlled, randomised study. Acta Paediatr. 2014 Jun;103(6):659–664.
   PubMed Web of Science ®Google Scholar
• Macarthur RD, Hawkins TN, Brown SJ, et al. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study. HIV Clin Trials. 2013;14:261–273.
   PubMed Web of Science ®Google Scholar
• Franceschi F, Scaldaferri F, Riccioni ME, et al. Management of acute diarrhea: current and future trends. Eur Rev Med Pharmacol Sci. 2014;18:2065–2069.
   PubMed Web of Science ®Google Scholar
• Çağan E, Ceylan S, Mengi Ş, et al. Evaluation of gelatin tannate against symptoms of acute diarrhea in pediatric patients. Med Sci Monit. 2017;23:2029–2034.
   PubMed Web of Science ®Google Scholar
• Michałek D, Kołodziej M, Konarska Z, et al. Efficacy and safety of gelatine tannate for the treatment of acute gastroenteritis in children: protocol of a randomised controlled trial. BMJ Open. 2016;6:e010530.
   PubMedGoogle Scholar
• Gnessi L, Bacarea V, Marusteri M, et al. Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial. BMC Gastroenterol. 2015;15:153.
   PubMed Web of Science ®Google Scholar
• Pleșea Condratovici C, Bacarea V, Piqué N. Xyloglucan for the treatment of acute gastroenteritis in children: results of a randomized, controlled, clinical trial. Gastroenterol Res Pract. 2016;2016:6874207.
   PubMed Web of Science ®Google Scholar
• Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011;1:111–114.
   PubMedGoogle Scholar
• Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 2016;4:124–137.
   PubMed Web of Science ®Google Scholar
• Kunz C, Meyer C, Collado MC, et al. Influence of gestational age, secretor, and Lewis blood group status on the oligosaccharide content of human milk. J Pediatr Gastroenterol Nutr. 2017;64:789–798.
   PubMed Web of Science ®Google Scholar
• Hamosh M, Peterson JA, Henderson TR, et al. Protective function of human milk: the milk fat globule. Semin Perinatol. 1999;23:242–249.
   PubMed Web of Science ®Google Scholar
• Bruggencate SJ, Frederiksen PD, Pedersen SM, et al. Dietary milk-fat-globule membrane affects resistance to diarrheagenic Escherichia coli in healthy adults in a randomized, placebo-controlled, double-blind study. J Nutr. 2016;146:249–255.
   PubMed Web of Science ®Google Scholar
• Sarker SA, Sultana S, Pietroni M, et al. Safety of a bioactive polyphenol dietary supplement in pediatric subjects with acute diarrhoea. Int J Pediatr. 2015;2015:387159.
   PubMedGoogle Scholar
• Noguera T, Wotring R, Melville CR, et al. Resolution of acute gastroenteritis symptoms in children and adults treated with a novel polyphenol-based prebiotic. World J Gastroenterol. 2014 Sep 14;20(34):12301–12307.
   PubMed Web of Science ®Google Scholar
• Dover A, Patel N, Park K. Rapid cessation of acute diarrhea using a novel solution of bioactive polyphenols: a randomized trial in Nicaraguan children. PeerJ. 2015;3:e969.
   PubMed Web of Science ®Google Scholar
• Thu HM, Myat TW, Win MM, et al. Chicken egg yolk antibodies (IgY) for prophylaxis and treatment of rotavirus diarrhea in human and animal neonates: a concise review. Kor J Food Sci Animl Resour. 2017;37:1–9.
   PubMed Web of Science ®Google Scholar
• Szajewska H. What are the indications for using probiotics in children? Arch Dis Child. 2016;101:398–403.
   PubMed Web of Science ®Google Scholar
• GBI Research. Gastrointestinal drugs market to Hit $48.4 billion [Internet]. Montville (NJ): Drug Development and Delivery; c2017; 2016 Oct 6. [cited 2017 May 10]. Available from: http://www.drug-dev.com/Main/Back-Issues/Gastrointestinal-Drugs-Market-to-Hit-484-Billion––1198.aspx
   Google Scholar
• Ja D, Hg G, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs [Internet]. Boston (MA): Tufts Center for the Study of Drug Development; c2017; 2014 Nov 18. [cited 2017 May 10]. Available from: http://csdd.tufts.edu/news/complete_story/cost_study_press_event_webcast
   Google Scholar